BlueCrest Capital Management’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

BlueCrest Capital Management’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-563,480	Closed	-$1.23M	–	706
2020 Q4	$1.23M	Sell	563,480 -807,591	-59%	-$1.6M	0.03%	279
2020 Q3	$2.41M	Sell	1,371,071 -589,820	-30%	-$1.01M	0.09%	164
2020 Q2	$2.67M	Sell	1,960,891 -128,231	-6%	-$160K	0.14%	111
2020 Q1	$1.97M	Buy	2,089,122 +225,969	+12%	+$278K	0.14%	87
2019 Q4	$2.85M	Buy	+1,863,153	New	+$2.63M	0.18%	90

Other funds holding NFH.WS

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return